Pursuant to 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that the CARE Ratings vide their letter No. CARE/HRO/RL/2025-26/1519 dated December 03, 2025 has reaffirmed/upgraded its ratings assigned to the bank facilities of the Company. The company has enclosed the summary of ratings for the Company. The rating letter received from CARE Ratings (CARE) is attached as Annexure.